在常规收集的医疗数据中识别主要先天性畸形的算法:系统回顾。

IF 3.8 2区 医学 Q1 PHARMACOLOGY & PHARMACY
Melanie H Jacobson, Meritxell Sabidó, Ana Sofia Afonso, Adebola Ajao, Eman A Alghamdi, Susan E Andrade, Dimitri Bennett, Vineetkumar Kharat, Marie-Laure Kürzinger, Maryline Le Noan-Lainé, Ditte Mølgaard-Nielsen, Gayle Murray, Elena Rivero-Ferrer, Sandra Lopez-Leon
{"title":"在常规收集的医疗数据中识别主要先天性畸形的算法:系统回顾。","authors":"Melanie H Jacobson, Meritxell Sabidó, Ana Sofia Afonso, Adebola Ajao, Eman A Alghamdi, Susan E Andrade, Dimitri Bennett, Vineetkumar Kharat, Marie-Laure Kürzinger, Maryline Le Noan-Lainé, Ditte Mølgaard-Nielsen, Gayle Murray, Elena Rivero-Ferrer, Sandra Lopez-Leon","doi":"10.1007/s40264-025-01606-w","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Major congenital malformations (MCMs) are a primary outcome of interest in pregnancy safety studies.</p><p><strong>Objective: </strong>This study aimed to identify and summarize algorithms used to identify MCMs in routinely collected healthcare data sources in the USA, Canada, and Europe by conducting a systematic literature review.</p><p><strong>Methods: </strong>We developed a search strategy to identify studies containing algorithms for MCMs from January 1, 2010, to April 11, 2025. Search terms included those related to MCMs as an outcome, routinely collected healthcare data, epidemiologic designs likely to incorporate algorithms, and pregnant individuals and/or infants. Study review and data extraction was conducted in duplicate using a standardized data collection form.</p><p><strong>Results: </strong>Among the initially identified 2242 studies, 974 were selected for full-text review. Of these, 70.3% were excluded, leaving 289 studies. Over half (58.1%) of the included studies were from Europe, predominantly from Nordic countries using national register data (N = 135; 80.4%). Studies using claims (18.0%) or hospital discharge data (16.3%) were also common. Although there was heterogeneity in the timing of MCM assessment, 55.7% of studies collected MCMs through the infant's first year of life. Overall, algorithms varied across data source type and geography in the codes specified, rules, utilization of maternal versus infant records, and coding system. There were 27 (9.3%) validation studies, 70.4% of which were based on claims and/or electronic health record data only. Most had positive predictive values >70%, though this varied according to MCM type or anatomical site.</p><p><strong>Conclusion: </strong>We provide the first comprehensive systematic literature review of algorithms used to identify MCMs in routinely collected healthcare data, aiding researchers in their ability to generate reliable evidence in pregnancy safety pharmacoepidemiology.</p>","PeriodicalId":11382,"journal":{"name":"Drug Safety","volume":" ","pages":""},"PeriodicalIF":3.8000,"publicationDate":"2025-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Algorithms to Identify Major Congenital Malformations in Routinely Collected Healthcare Data: A Systematic Review.\",\"authors\":\"Melanie H Jacobson, Meritxell Sabidó, Ana Sofia Afonso, Adebola Ajao, Eman A Alghamdi, Susan E Andrade, Dimitri Bennett, Vineetkumar Kharat, Marie-Laure Kürzinger, Maryline Le Noan-Lainé, Ditte Mølgaard-Nielsen, Gayle Murray, Elena Rivero-Ferrer, Sandra Lopez-Leon\",\"doi\":\"10.1007/s40264-025-01606-w\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Major congenital malformations (MCMs) are a primary outcome of interest in pregnancy safety studies.</p><p><strong>Objective: </strong>This study aimed to identify and summarize algorithms used to identify MCMs in routinely collected healthcare data sources in the USA, Canada, and Europe by conducting a systematic literature review.</p><p><strong>Methods: </strong>We developed a search strategy to identify studies containing algorithms for MCMs from January 1, 2010, to April 11, 2025. Search terms included those related to MCMs as an outcome, routinely collected healthcare data, epidemiologic designs likely to incorporate algorithms, and pregnant individuals and/or infants. Study review and data extraction was conducted in duplicate using a standardized data collection form.</p><p><strong>Results: </strong>Among the initially identified 2242 studies, 974 were selected for full-text review. Of these, 70.3% were excluded, leaving 289 studies. Over half (58.1%) of the included studies were from Europe, predominantly from Nordic countries using national register data (N = 135; 80.4%). Studies using claims (18.0%) or hospital discharge data (16.3%) were also common. Although there was heterogeneity in the timing of MCM assessment, 55.7% of studies collected MCMs through the infant's first year of life. Overall, algorithms varied across data source type and geography in the codes specified, rules, utilization of maternal versus infant records, and coding system. There were 27 (9.3%) validation studies, 70.4% of which were based on claims and/or electronic health record data only. Most had positive predictive values >70%, though this varied according to MCM type or anatomical site.</p><p><strong>Conclusion: </strong>We provide the first comprehensive systematic literature review of algorithms used to identify MCMs in routinely collected healthcare data, aiding researchers in their ability to generate reliable evidence in pregnancy safety pharmacoepidemiology.</p>\",\"PeriodicalId\":11382,\"journal\":{\"name\":\"Drug Safety\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":3.8000,\"publicationDate\":\"2025-09-13\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Drug Safety\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s40264-025-01606-w\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug Safety","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s40264-025-01606-w","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

摘要

重大先天性畸形(mcm)是妊娠安全性研究的主要结果。目的:本研究旨在通过系统的文献综述,识别和总结用于识别美国、加拿大和欧洲常规收集的医疗保健数据源中的mcm的算法。方法:从2010年1月1日至2025年4月11日,我们开发了一种搜索策略来识别包含mcm算法的研究。搜索条件包括与mcm相关的结果、常规收集的医疗保健数据、可能包含算法的流行病学设计以及孕妇和/或婴儿。采用标准化数据收集表进行研究回顾和数据提取,一式两份。结果:在最初确定的2242项研究中,974项被选为全文综述。其中,70.3%被排除,剩下289项研究。超过一半(58.1%)的纳入研究来自欧洲,主要来自北欧国家,使用国家登记数据(N = 135; 80.4%)。使用索赔(18.0%)或出院数据(16.3%)的研究也很常见。尽管MCM评估的时间存在异质性,但55.7%的研究在婴儿出生后的第一年收集了MCM。总体而言,在指定的代码、规则、母婴记录的利用以及编码系统方面,算法因数据源类型和地理而异。共有27项(9.3%)验证研究,其中70.4%仅基于索赔和/或电子健康记录数据。大多数阳性预测值约为70%,尽管这根据MCM类型或解剖部位而有所不同。结论:我们首次对常规收集的医疗数据中用于识别mcm的算法进行了全面系统的文献综述,帮助研究人员在妊娠安全药物流行病学方面获得可靠的证据。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Algorithms to Identify Major Congenital Malformations in Routinely Collected Healthcare Data: A Systematic Review.

Introduction: Major congenital malformations (MCMs) are a primary outcome of interest in pregnancy safety studies.

Objective: This study aimed to identify and summarize algorithms used to identify MCMs in routinely collected healthcare data sources in the USA, Canada, and Europe by conducting a systematic literature review.

Methods: We developed a search strategy to identify studies containing algorithms for MCMs from January 1, 2010, to April 11, 2025. Search terms included those related to MCMs as an outcome, routinely collected healthcare data, epidemiologic designs likely to incorporate algorithms, and pregnant individuals and/or infants. Study review and data extraction was conducted in duplicate using a standardized data collection form.

Results: Among the initially identified 2242 studies, 974 were selected for full-text review. Of these, 70.3% were excluded, leaving 289 studies. Over half (58.1%) of the included studies were from Europe, predominantly from Nordic countries using national register data (N = 135; 80.4%). Studies using claims (18.0%) or hospital discharge data (16.3%) were also common. Although there was heterogeneity in the timing of MCM assessment, 55.7% of studies collected MCMs through the infant's first year of life. Overall, algorithms varied across data source type and geography in the codes specified, rules, utilization of maternal versus infant records, and coding system. There were 27 (9.3%) validation studies, 70.4% of which were based on claims and/or electronic health record data only. Most had positive predictive values >70%, though this varied according to MCM type or anatomical site.

Conclusion: We provide the first comprehensive systematic literature review of algorithms used to identify MCMs in routinely collected healthcare data, aiding researchers in their ability to generate reliable evidence in pregnancy safety pharmacoepidemiology.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Drug Safety
Drug Safety 医学-毒理学
CiteScore
7.60
自引率
7.10%
发文量
112
审稿时长
6-12 weeks
期刊介绍: Drug Safety is the official journal of the International Society of Pharmacovigilance. The journal includes: Overviews of contentious or emerging issues. Comprehensive narrative reviews that provide an authoritative source of information on epidemiology, clinical features, prevention and management of adverse effects of individual drugs and drug classes. In-depth benefit-risk assessment of adverse effect and efficacy data for a drug in a defined therapeutic area. Systematic reviews (with or without meta-analyses) that collate empirical evidence to answer a specific research question, using explicit, systematic methods as outlined by the PRISMA statement. Original research articles reporting the results of well-designed studies in disciplines such as pharmacoepidemiology, pharmacovigilance, pharmacology and toxicology, and pharmacogenomics. Editorials and commentaries on topical issues. Additional digital features (including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations) can be published with articles; these are designed to increase the visibility, readership and educational value of the journal’s content. In addition, articles published in Drug Safety Drugs may be accompanied by plain language summaries to assist readers who have some knowledge of, but not in-depth expertise in, the area to understand important medical advances.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信